The application before a drug mention and a no-show

The application that later shows a drug mention and an empty chair has a recognisable shape: a short recent stint nobody explains, a start date that cannot wait, and a pre-employment test scheduled before anyone has read what previous carriers wrote. None of it is disqualifying on its own. Together it is the file worth a second call.

This is a typical application, assembled from how drugs-or-alcohol and no-show reviews cluster together. It is not one person’s file. There is no name, no carrier, no state, and no week attached to it. If it feels familiar, that is the point of a pattern.

Among the reviews carriers left on CDLScan, 11.7% mention drugs or alcohol. That figure describes those reviews, not drivers in general: carriers write after a bad run, so the share tells you what shows up once someone bothers to report it. Inside that slice, 14.5% also mention a no-show — 14.5% of drugs-or-alcohol reviews, not of all reviews. Flip the pair and 31.7% of no-show reviews also mention drugs or alcohol. No-shows are 5.3% of all reviews. Seeing them in 14.5% of drugs-or-alcohol reviews is about 2.7 times the chance rate. Lift is that multiplier, not the odds on your next clinic slot. How those shares are counted is on the methodology page.

Here is the application that pairing keeps producing.

What the file looks like on Monday

Two employers in the last year, maybe three. One stint is short enough that you would want a sentence about it and you do not get one. There is a hole of a few months. References are listed. They are slow. The MVR is dull. PSP is dull. Clearinghouse is clear.

The urgency is not in the reports. It is in the calendar. They can start this week. Orientation is Tuesday. The clinic is Monday afternoon. Can you schedule today.

Nothing on that page is disqualifying. Plenty of good hires have a messy year and need a fast start. The pattern is the combination: thin recent history, slow last employer, official packet quiet, and the spend pulled forward before anyone has read what previous carriers wrote.

The language that later shows up in the reviews is already sitting in that request: drug test, pre-employment, next day, never showed. The no-show language is not on the application yet. It arrives after you have paid for the slot — never showed, didn’t show, didn’t make orientation.

What happens after you say yes

Typical next step, still a composite: the test is scheduled. They confirm. The day before the answers get shorter, or the phone just stops. Monday the chair is empty. Sometimes they land and never walk into the clinic. Sometimes a flight was on the same invoice. In 16.0% of drugs-or-alcohol reviews the carrier also mentions paid travel with no arrival, so that last version is not exotic.

In 12.2% of those same reviews the carrier also mentions going unreachable. That is the version where you find out from the clinic, not from the candidate. The pairing with a silent phone is in a drug mention next to going unreachable.

What usually does not happen next is an abandoned truck. Only 10.3% of drugs-or-alcohol reviews also mention one. This application is the person who never takes the unit, not the person who takes it and leaves it at a stop. If you screen this file the way you screen a walk-off, you will stare at the wrong field. The split is unpacked in two failure populations that barely overlap. The pairing itself is in a drug mention that often arrives with a no-show.

The share of reviews mentioning drugs or alcohol ran 13.6% in 2018, 12.1% in 2019, 13.0% in 2020, 14.7% in 2021, 11.8% in 2022, 10.9% in 2023, 10.2% in 2024, and 11.2% in 2025. I stop that line at 2025. 2021 is the high you should not smooth over. Then the share stepped down. 2025 is lower than 2018, not gone.

No-show mentions moved from 3.7% in 2018 to 4.9% in 2025. The drug-and-alcohol line eased. The empty chair did not. The application above did not get any rarer. The packet you run on it did not get any better at describing it.

Why the packet stayed quiet

PSP, an MVR, and the Clearinghouse hold what someone filed. This candidate has not taken your truck. There is no crash to record and no roadside inspection. A previous-employer form may return dates from a short stint and a blank rehire box, or it may not return at all because the last desk never really onboarded them.

A Clearinghouse hit can sit next to this story — when a test was actually taken and reported. The empty chair itself never becomes a query result. Official reports can still be useful for other things on the same person. They are silent on this event.

The useful record is the last recruiter’s write-up: we scheduled the test, they never showed. That sentence does not have a field on the reports you already buy. It sits in what carriers bother to leave when the invoice is still on their desk.

A clean packet on this application means the filed items are clean. It does not mean the clinic slot will be used. The drug-mention trend itself is in a drug mention that is often a missed test. The no-show side is in a no-show as onboarding spend.

What I would have done with that file

I would not reject it on sight. I would stop the purchase.

Look the name up first. If previous carriers already wrote about a drug test and a never-showed, the next clinic slot is a decision, not a courtesy. If the last employer will not say why the stint ended, that is not a pass. Ask the candidate when they can start if the test waits two days. People choosing between real seats can usually wait. People who need the slot as the job push the charge forward.

If a flight is part of the same week, do not put the ticket on the card until the test is actually in motion. The reviews keep putting a test and a missing candidate in the same paragraph. That is not a reason to turn this into a medical article. It is a reason not to pay for night two before morning one.

Then, if the write-ups are clean and the last employer talks, schedule the test. The point of a composite is not to make you cruel. It is to put the spend after the read.

Check the name on CDLScan before the slot is paid. It takes less than a minute. On this pattern, that minute is the job.

Frequently asked questions

Is this a real driver?

No. It is a typical application built from how drugs-or-alcohol and no-show reviews cluster. No name, no carrier, no date. If your current file matches it, that is the pattern talking, not a biography.

Does 14.5% mean this application usually no-shows?

No. 14.5% is the share of drugs-or-alcohol reviews that also mention a no-show, among reviews carriers left on CDLScan. Most drugs-or-alcohol write-ups do not include a no-show. The pairing is far above chance. It is not a majority.

Why didn’t PSP catch it?

There was nothing to file. A scheduled test and an empty chair are not a crash or an inspection. Official reports can still be useful for other things on the same person. They are silent on this event.

Should I stop scheduling pre-employment tests?

No. Stop paying for the slot before you have read what previous carriers wrote, and before the last employer has answered. The spend is the risk. The test is not the crime.

What if the candidate has a clean Clearinghouse query?

Then the program events are clean. In this composite the failure is the empty chair, which is not a query result. A clean query does not make the clinic slot free.

What is the one question that changes the week?

“When can you start if I do not schedule the test today?” Combined with a name search, that question sorts urgency from need more honestly than a rehire box.

Where do I read the previous write-ups?

On CDLScan, before you book the slot. The pairing is already on the record more often than chance. Read it while the money is still yours.